89 related articles for article (PubMed ID: 7796386)
1. On the relationship between rate of uptake of Photofrin and cellular responses to photodynamic treatment in vitro.
Gantchev TG; Urumov IJ; Van Lier JE
Cancer Biochem Biophys; 1994 Apr; 14(1):23-34. PubMed ID: 7796386
[TBL] [Abstract][Full Text] [Related]
2. Cellular accumulation and biological activity of hematoporphyrin derivative(L) in comparison with photofrin II.
Khanum F; Jain V
Indian J Exp Biol; 1997 Apr; 35(4):348-55. PubMed ID: 9315233
[TBL] [Abstract][Full Text] [Related]
3. Cellular binding of hematoporphyrin derivative (HpD) in human bladder cancer cell line: KK-47.
Hisazumi H; Miyoshi N; Ueki O; Nakajima K
Prog Clin Biol Res; 1984; 170():443-57. PubMed ID: 6241690
[TBL] [Abstract][Full Text] [Related]
4. Lack of reciprocity in drug and light dose dependence of photodynamic therapy of pancreatic adenocarcinoma in vitro.
Moesta KT; Greco WR; Nurse-Finlay SO; Parsons JC; Mang TS
Cancer Res; 1995 Jul; 55(14):3078-84. PubMed ID: 7606730
[TBL] [Abstract][Full Text] [Related]
5. Subcellular localization of Photofrin and aminolevulinic acid and photodynamic cross-resistance in vitro in radiation-induced fibrosarcoma cells sensitive or resistant to photofrin-mediated photodynamic therapy.
Wilson BC; Olivo M; Singh G
Photochem Photobiol; 1997 Jan; 65(1):166-76. PubMed ID: 9066298
[TBL] [Abstract][Full Text] [Related]
6. Subcellular localization of Photofrin determines the death phenotype of human epidermoid carcinoma A431 cells triggered by photodynamic therapy: when plasma membranes are the main targets.
Hsieh YJ; Wu CC; Chang CJ; Yu JS
J Cell Physiol; 2003 Mar; 194(3):363-75. PubMed ID: 12548556
[TBL] [Abstract][Full Text] [Related]
7. Photosensitization, uptake, and retention of phenoxazine Nile blue derivatives in human bladder carcinoma cells.
Lin CW; Shulok JR; Wong YK; Schanbacher CF; Cincotta L; Foley JW
Cancer Res; 1991 Feb; 51(4):1109-16. PubMed ID: 1847656
[TBL] [Abstract][Full Text] [Related]
8. [Effect of L-lysine-alpha-oxidase on the cell cycle kinetics of cultured Burkitt's lymphoma cells].
Zhukova OS; Khaduev SKh; Dobrynin IaV; Smirnova MP; Lukasheva EV
Eksp Onkol; 1985; 7(6):42-4. PubMed ID: 4085397
[TBL] [Abstract][Full Text] [Related]
9. In vitro photodynamic therapy of human lung cancer: investigation of dose-rate effects.
Matthews W; Cook J; Mitchell JB; Perry RR; Evans S; Pass HI
Cancer Res; 1989 Apr; 49(7):1718-21. PubMed ID: 2522346
[TBL] [Abstract][Full Text] [Related]
10. Hypericum perforatum L. extract - novel photosensitizer against human bladder cancer cells.
Stavropoulos NE; Kim A; Nseyo UU; Tsimaris I; Chung TD; Miller TA; Redlak M; Nseyo UO; Skalkos D
J Photochem Photobiol B; 2006 Jul; 84(1):64-9. PubMed ID: 16540336
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological evaluation of folic acid targeted tetraphenylporphyrin as novel photosensitizers for selective photodynamic therapy.
Schneider R; Schmitt F; Frochot C; Fort Y; Lourette N; Guillemin F; Müller JF; Barberi-Heyob M
Bioorg Med Chem; 2005 Apr; 13(8):2799-808. PubMed ID: 15781391
[TBL] [Abstract][Full Text] [Related]
12. Chromosomal proteins HMG-14 and HMG-17 are synthesized throughout the S-phase in Burkitt's lymphoma.
Morton RL; David H; O'Connor PM; Bustin M
Biochem Biophys Res Commun; 1996 May; 222(2):368-73. PubMed ID: 8670211
[TBL] [Abstract][Full Text] [Related]
13. Phototoxicity, redox behavior, and pharmacokinetics of benzophenoxazine analogues in EMT-6 murine sarcoma cells.
Cincotta L; Foley JW; Cincotta AH
Cancer Res; 1993 Jun; 53(11):2571-80. PubMed ID: 8495421
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of CDDP cytotoxicity by caffeine is characterized by apoptotic cell death.
Shinomiya N; Shinomiya M; Wakiyama H; Katsura Y; Rokutanda M
Exp Cell Res; 1994 Feb; 210(2):236-42. PubMed ID: 8299722
[TBL] [Abstract][Full Text] [Related]
15. Photofrin uptake by murine macrophages.
Korbelik M; Krosl G; Chaplin DJ
Cancer Res; 1991 May; 51(9):2251-5. PubMed ID: 1826630
[TBL] [Abstract][Full Text] [Related]
16. In vitro photodynamic activity of chloro(5,10,15,20-tetraphenylporphyrinato)indium(III) loaded-poly(lactide-co-glycolide) nanoparticles in LNCaP prostate tumour cells.
da Silva AR; Inada NM; Rettori D; Baratti MO; Vercesi AE; Jorge RA
J Photochem Photobiol B; 2009 Feb; 94(2):101-12. PubMed ID: 19070504
[TBL] [Abstract][Full Text] [Related]
17. S-nitrosoglutathione photolysis as a novel therapy for antifibrosis in filtration surgery.
Tannous M; Hutnik CM; Tingey DP; Mutus B
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):749-55. PubMed ID: 10711690
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients.
Bellnier DA; Greco WR; Loewen GM; Nava H; Oseroff AR; Pandey RK; Tsuchida T; Dougherty TJ
Cancer Res; 2003 Apr; 63(8):1806-13. PubMed ID: 12702566
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor effect of PDT using Photofrin in a mouse angiosarcoma model.
Jin I; Yuji M; Yoshinori N; Makoto K; Mikio M
Arch Dermatol Res; 2008 Apr; 300(4):161-6. PubMed ID: 18080130
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro.
Dysart JS; Patterson MS
Phys Med Biol; 2005 Jun; 50(11):2597-616. PubMed ID: 15901957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
